Trial Profile
Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary) ; Iron sucrose (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms PRIME
- 16 Feb 2021 Status changed from active, no longer recruiting to completed.
- 18 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2016 New trial record